Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1910833

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C[C@@]1(CO)CC[C@]2(C(=O)O)[C@H](O)C[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CCC(=O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1

Basic Information

ChEMBL ID CHEMBL1910833
Phase Preclinical
Structure Type MOL
InChI Key XRUBFYYNZLBFBN-JYGFFPNFSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

502.7
MW (Da)
4.36
ALogP
5
HBA
4
HBD
115.1
PSA (Ų)
0.43
QED
1
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C30H46O6
MW 502.69
Aromatic Rings 0
Heavy Atoms 36
NP-Likeness 3.53

Activity Summary

IC50 1 meas. best 5.19

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.19 5.19 6500.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 6500.0 nM 5.19 Inhibition of TNF-alpha-induced NFkappaB activation in human HepG2 cells after 1... 21870831

Literature References

PubMed DOI Target Context # Activities
21870831 10.1021/np200382s Unchecked 3
21870831 10.1021/np200382s HepG2 1

Data from ChEMBL 36 via Core Engine